Acute toxicity of two Alzheimer's disease radiopharmaceuticals: FDDNP and IMPY

Drug and Chemical Toxicology

Volumn 32, Issue 4, 2009, Pages 429-437

  Chang, Kang Wei ^a,b   Chen, Chia Chieh ^b   Lee, Shih Ying ^b   Wang, Hsin Ell ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

Author keywords

Alzheimers disease; FDDNP; IMPY; Toxicity

Indexed keywords

2 [1 [6 [(2 FLUOROETHYL)METHYLAMINO] 2 NAPHTHYL]ETHYLIDENE]MALONONITRILE; 6 IODO 2 (4' DIMETHYLAMINO)PHENYLIMIDAZO[1,2 A]PYRIDINE; IMIDAZO[1,2 A]PYRIDINE DERIVATIVE; MALONONITRILE; UNCLASSIFIED DRUG; 2,3 DIHYDRO 1H IMIDAZO[1,2 B]PYRAZOLE; 2,3-DIHYDRO-1H-IMIDAZO(1,2-B)PYRAZOLE; AMYLOID BETA PROTEIN; DIAGNOSTIC AGENT; FLUORESCENT DYE; FLUORODEOXYGLUCOSE F 18; PYRAZOLE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ACUTE TOXICITY; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG SYNTHESIS; EARLY DIAGNOSIS; FEMALE; LIVER INJURY; MALE; MORTALITY; NONHUMAN; RADIODIAGNOSIS; RAT; TOXICITY TESTING; ANIMAL; BRAIN; CHEMISTRY; DEGENERATIVE DISEASE; DEMENTIA; HUMAN; IMAGE ENHANCEMENT; METABOLISM; NEUROFIBRILLARY TANGLE; TISSUE DISTRIBUTION;

ANIMALIA; RATTUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; DEMENTIA; FEMALE; FLUORESCENT DYES; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; MALE; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; PYRAZOLES; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 74049151575     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540903127324     Document Type: Article

References (19)

1. Agdeppa, E. D., Kepe. V., Liu, J., Flores-Torres, S., Satyamurthy, N., Petric, A., et al. (2001). Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci 21:RC189.
2. Agdeppa, E. D., Kepe, V., Liu, J., Small, G. W., Huang, S. C., Petric, A., et al. (2003b). 2-dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. Mol Imaging Biol 5:404-417.
3. Agdeppa, E. D., Kepe, V., Petri, A., Satyamurthy, N., Liu, J., Huang, S. C., et al. (2003a). In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F]fluoroethyl)(methyl) amino]- 2-naphthyl]ethylidene)malononitrile. Neuroscience 117:723-730.
4. Barrio, J. R. Kepe, V., Satyamurthy, N., Huang, S. C., Small, G. W. (2006). Brain pathology and neuronal losses in the living brain of Alzheimer's patients. Int Congr Series 1290:150-155. (Pubitemid 43850885)
5. Brendza, R. P., Bacskai, B. J., Cirrito, J. R., Simmons, K. A., Skoch, J. M., Klunk, W. E., et al. (2005). Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest 15:428-433.
6. Cleary, J., Hittner, J. M., Semotuk, M., Mantyh, P., O'Hare, E. (1995). Beta-amyloid (1-40) effects on behavior and memory. Brain Res 682(1-2):69-74.
7. Gordon, M. N., King, D. L., Diamond, D. M., Jantzen, P. T., Boyett, K. V., Hope, C. E., et al. (2001). Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol Aging 22:377-385.
8. Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P., Mathis, C. A. (2001). Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69:1471-1484.
9. Kulkarni, P. V., Arora V., Roney, A. V., White, C., III, Bennett, M., Antich, P. P., (2005). Radiolabeled probes for imaging Alzheimer's plaques. Nucl Instr Meth Phys Res B 241:676-680.
10. Kung, M. P., Hou, C., Zhuang, Z. P., Skovronsky, D., Kung. H. F. (2004a). Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease. Brain Res 1025(1-2):98-105.
11. Kung, M. P., Hou, C., Zhuang, Z. P., Cross, A. J., Maier, D. L., Kung, H. F. (2004b). Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice. Eur J Nucl Med Mol Imaging 31:1136-1145.
12. Kung, M. P., Hou, C., Zhuang, Z. P., Zhang, B., Skovronsky, D., Trojanowski, J. Q., et al. (2002). IMPY: an improved thioflavin- T derivative for in vivo labeling of beta-amyloid plaques. Brain Res 956:202-210.
13. Kung, H. F., Kung, M. P., Zhuang, Z. P., Hou, C., Lee, C. W., Plossl, K., et al. (2003). Iodinated tracers for imaging amyloid plaques in the brain. Mol Imaging Biol 5:418-426.
14. Lee, C. W., Kung, M. P., Hou, C., Kung, H. F. (2003). Dimethylaminofluorenes: ligands for detecting beta-amyloid plaques in the brain. Nucl Med Biol 30:573-580.
15. Liu, J., Kepe, V., Zabjek, A., Petric, A., Padgett, H. C., Satyamurthy, N., et al. (2007). High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F] fluoroethyl) (methyl)amino]- 2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration. Mol Imaging Biol 9:6-16.
16. Nakamura, S., Murayama, N., Noshita, T., Annoura, H., Ohno, T. (2001). Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res 912:128-136.
17. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., et al. (2003). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421.
18. Reiman, E. M., Uecker, A., Gonzalez-Lima, F., Minear, D., Chen, K., Callaway, N. L., et al. (2000). Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography. Neuroreport 11:987-991
19. Selkoe, D. J. (2000). The origins of Alzheimer's disease: a is for amyloid. JAMA 283:1615-1617.